• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Aiforia Technologies

1.08 EUR0.00 %14.8, 17.29
2,220 following

AIFORIA

First North Finland

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
0.00 %
-39.46 %
-44.27 %
-42.55 %
-56.63 %
-67.86 %
-75.51 %
-
-78.66 %

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more
Market cap
40.38M EUR
Turnover
22.79K EUR
P/E (adj.) (26e)
-3.7
EV/EBIT (adj.) (26e)
-3.93
P/B (26e)
3.02
EV/S (26e)
14.22
Dividend yield-% (26e)
-
Coverage
Recommendation
Reduce
Target price
1.30 EUR
Updated
22.07.2026
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 23.07.2026

Latest extensive report

Released: 24.04.2025

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
European Investment Bank TECHEU VD AI FOR IMAGING ANALYSIS (BIOTECH ACT) The project focuses on developing and deploying an advanced, cloud-based AI platform for digital pathology that enables expert guided training, validation, and application of image analysis models for clinical...
8/10/2026, 5:29 AM
by Salvelinus
10
Have you used this: Kukaomistaa.fi — Helsinki Stock Exchange ownership register. It is easy and clear to use, and the information seems to be accurate when using public registers.
8/5/2026, 7:31 AM
10
Any financing solution that is good for the shareholders requires favorable sales development for Aiforia. If that doesn’t happen, the share will eventually go to zero. In that sense, I don’t understand how this is seen as a negative point regarding the financing… if we were to continue...
8/3/2026, 7:39 AM
by Puutaheinää
9
An EIB director from the division in question is also highlighting this Aiforia funding on LinkedIn. LinkedIn #ai #life #investeu | Y Zhang 💡Linking #AI and #Life Sciences. ☝️An excellent project illustrating the efforts of the European Investment Bank (EIB) in partnership with the...
8/10/2026, 6:15 AM
by Puutaheinää
8
I have kept a relatively small tracking position, which I have then steadily topped up on dips—perhaps foolishly, but blindly believing in domestic success on the global stage. The thinking is that: Aiforia succeeds in getting its field integrations and installation times to a level...
8/3/2026, 9:42 AM
by Pekka
7
After the severe profit warning, I didn’t think it was at all certain that the EIB (European Investment Bank) letter of intent would still reach the finish line. In that sense, that news on Friday was positive for me.
8/3/2026, 6:59 AM
by Puutaheinää
7
Now that there is faith from the EU, how can public hospitals be encouraged to accelerate adoption? That is a tough nut for Aiforia to crack, and it won’t be easy. It is not enough for the product/service to be good; it also has to convince the users. Among them are some old-school...
8/1/2026, 10:58 AM
by Matti
7
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.8
2026

Interim report Q2'26

Aiforia secured a 20 MEUR financing agreement with the EIB
Analyst Comment03.08.2026, 08.19 by
Antti Siltanen, Antti Luiro

Aiforia secured a 20 MEUR financing agreement with the EIB

The loan arrangement secures financing for the coming years, provided the business develops favorably.

Aiforia Technologies
Regulatory press release31.07.2026, 17.00

Aiforia and the European Investment Bank have signed an agreement for EUR 20 million venture debt financing

Aiforia Technologies
Regulatory press release24.07.2026, 10.00

Aiforia Technologies Plc – Managers’ Transactions – Jukka Tapaninen

Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research23.07.2026, 09.04

Aiforia Technologies: Aiforia H1 profit warning triggers downgrade to HOLD - NuWays AG Research

Aiforia issued a profit warning with H1'26 revenues coming in at a mere € 0.75m, down from € 1.4m in H1'25 (-46% yoy), against our expectation of roughly doubling yoy, following last year's strong Clinical momentum (organic growth of +65%). At the same...

Aiforia Technologies
Aiforia: We diagnose a growth deficiency
Research23.07.2026, 09.25 by
Antti Siltanen

Aiforia: We diagnose a growth deficiency

The ongoing uncertainty regarding growth is causing us to take a negative view of the risk-reward ratio.

Aiforia Technologies
Aiforia's H1 revenue was surprisingly subdued
Analyst Comment22.07.2026, 08.05 by
Antti Siltanen

Aiforia's H1 revenue was surprisingly subdued

The conversion of customer wins into revenue continues to be slow.

Aiforia Technologies
Regulatory press release21.07.2026, 17.40

Inside information, profit warning: Aiforia's revenue developed below the estimates during January–June 2026

Aiforia Technologies
Regulatory press release06.07.2026, 08.00

Aiforia Technologies Plc – Managers’ Transactions – Tuomas Tenkanen

Aiforia Technologies
Regulatory press release06.07.2026, 08.00

Aiforia Technologies Plc – Managers’ Transactions – Johan Lundin

Aiforia Technologies
Regulatory press release01.07.2026, 20.00

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Acme Investments SPF Sarl)

Aiforia Technologies
Third party research29.06.2026, 09.21

Aiforia Technologies: € 6.4m share issue de-risks the investment case - NuWays AG Research

On Thursday evening, Aiforia announced having completed a directed share issue of 3.6m shares at € 1.772 per share, raising gross proceeds of some € 6.4m. The subscription price corresponds to the closing price of June 25th, representing no discount ...

Aiforia Technologies
Regulatory press release26.06.2026, 15.30

Aiforia Technologies Plc – Managers’ Transactions – Tuomas Tenkanen

Aiforia Technologies
Regulatory press release26.06.2026, 15.20

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act (Tuomas Tenkanen/TJT Technologies Oy)

Aiforia Technologies
Regulatory press release26.06.2026, 11.15

A total of 3,600,000 new shares in Aiforia Technologies Plc registered with the Trade Register

Aiforia Technologies
Aiforia collects 6.4 MEUR in a directed share issue
Analyst Comment26.06.2026, 07.49 by
Antti Siltanen

Aiforia collects 6.4 MEUR in a directed share issue

The company's financial risk in the coming years will diminish if the planned EIB loan materializes in addition to the share issue.

Aiforia Technologies
Regulatory press release25.06.2026, 21.00

Inside information: Aiforia Technologies Plc successfully completes a directed share issue raising approximately EUR 6.4 million

Aiforia Technologies
Regulatory press release25.06.2026, 17.31

Inside information: Aiforia Technologies Plc intends to carry out a directed share issue by means of an accelerated bookbuilding process

Aiforia Technologies
Third party research17.06.2026, 08.21

Aiforia Technologies: €20m EIB debt term sheet de-risks Aiforia's funding outlook - NuWays AG Research

Aiforia agrees non-binding EIB term sheet for up to €20m venture debt, materially de-risking the funding outlook. BUY, PT €3.80 unchanged.

Aiforia Technologies
Aiforia indicatively agreed on a 20 MEUR financing facility with the EIB
Analyst Comment16.06.2026, 08.16 by
Antti Siltanen, Antti Luiro

Aiforia indicatively agreed on a 20 MEUR financing facility with the EIB

The financing package would significantly reduce the short-term financing risk.

Aiforia Technologies
Regulatory press release15.06.2026, 20.45

Inside information: Aiforia and the European Investment Bank agree upon a non-binding indicative term sheet for an up to EUR 20 million venture debt financing facility

Aiforia Technologies